Meeting to be held in New York on July 22 hosted by B. Riley.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVID:
- Ovid Therapeutics Approves Key Proposals at Annual Meeting
- Ovid Therapeutics Sells Ganaxolone Royalties to Immedica
- Ovid enters agreement with Immedica for sale of future ganaxolone royalties
- Ovid Therapeutics: Promising Buy Opportunity with OV329 Advancements in Drug-Resistant Epilepsy
- Positive Outlook for Ovid Therapeutics: Buy Rating Supported by Promising OV329 Drug and Strategic Pipeline Development